RadConnect Communication Application

Communication Clinical Trial

— RadConnect  

Official title:

RadConnect Communication Application

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT05540444
• Other study ID #: ICBE-S-000556
• Status: Completed
• Start date: September 29, 2022
• Est. completion date: July 13, 2023

Study information

• Verified date: July 2023
• Source: Philips Electronics Nederland B.V. acting through Philips CTO organization
• Contact: n/a
• Is FDA regulated: No
• Study type: Observational

Clinical Trial Summary

The aim is to evaluate the impact of an innovative asynchronous communication application on the number of calls from technologists to radiologists. Even though it is paramount that radiologists be accessible and available to other healthcare workers in the enterprise, frequent interruptions have negative impact on productivity and well-being. A novel communication app was developed that streamlines communication between technologists and radiologists: RadConnect.

Recruitment information / eligibility

• Status: Completed
• Enrollment: 79
• Est. completion date: July 13, 2023
• Est. primary completion date: July 13, 2023
• Accepts healthy volunteers: Accepts Healthy Volunteers
• Gender: All
• Age group: N/A and older

Eligibility

Inclusion Criteria:

• Individuals that are employed by LUMC
• Individuals that are radiologists, radiology fellows, radiology residents, radiology technologists, doctor assistants, physician assistants or other support personnel in the Department of Radiology that raise managing image acquisition related questions.
• Individuals that consent to participating in the study.
• Individuals scheduled to work at locations at Sending Extensions, Receiving Extensions and Control Extensions.

Exclusion Criteria:

• Individuals not able to understand or not willing to sign the informed consent form.
• Individuals that indicate that they do no comprehend RadConnect and/or its intended use after two educational sessions.
• Individuals not able to not willing to comply with the intended use of RadConnect.

Related Conditions & MeSH terms

• Communication

Intervention

Device:
• RadConnect
The study will be performed in a clinical setting at the department of radiology of LUMC, meaning that we aim to test the hypothesis that ("RadConnect") can reduce the number of phone calls from a select set of extension used by technologists (the "Sending Extensions") to another select set of extensions manned by radiologists ("Receiving Extensions").

Locations

Country	Name	City	State
Netherlands	Leiden University Medical Center (LUMC)	Leiden

Sponsors (2)

Lead Sponsor	Collaborator
Philips Electronics Nederland B.V. acting through Philips CTO organization	Leiden University Medical Center

Country where clinical trial is conducted

Netherlands, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Test the hypothesis that adoption of RadConnect leads to reduction of phone calls to radiologists.	P1 = Mean number of calls per working day during regular working hours between Sending Extensions and Receiving Extensions in Before Phase; P2 = Mean number of calls per working day during regular working hours between Sending Extensions and Receiving Extensions in After Phase; The primary endpoint will be obtained by testing the hypothesis that P1 > P2 using Wilcoxon's one-tailed test with significance level P < 0.05.	Numbers are continously measured during each shift of the subjects over a period of 40 consecutive working days during the before (phase 1) and 40 consecutive working days during the after phase (phase 2) of this study.
Secondary	Compare experiences and attitudes of technicians and radiologists towards RadConnect versus phone calls.	C1 = Mean number of calls per working day during regular working hours between Sending Extensions and Control Extensions in Before Phase; C2 = Mean number of calls per working day during regular working hours between Sending Extensions and Control Extensions in After Phase; The first secondary endpoint will be obtained by testing the hypothesis that C1 ? C2 using Wilcoxon's two-tailed test with significance level P < 0.05.	Continously measured during each shift of the subjects over a period of 40 consecutive working days during the before (phase 1) and 40 consecutive working days during the after phase(phase 2) of this study.
Secondary	Measure the characteristics of technician questions raised over phone and through RadConnect.	• R2 = Mean number of completed RadConnect consultations per working day during regular working hours between Sending Extensions and Receiving Extensions in After Phase; The second secondary endpoint will be obtained by testing the hypothesis that P1 ? P2 + R2 using Wilcoxon's two-tailed test with significance level P < 0.05.	Continously measured during each shift of the subjects over a period of 40 consecutive working days during the before phase (phase 1) and 40 consecutive working days during the after phase (phase 2) of this study.
Secondary	Consolidated opinion usability and experience of RadConnect in itself and in comparison to alternative communication methods.	The third secondary endpoint will be obtained by aggregating survey responses. In the structured online survey, if more than half of the respondents indicate that they prefer communication over RadConnect to calling, it will be concluded that RadConnect is a viable alternative to calling. If more than half of radiologist respondents indicate that they believe RadConnect helps them avoid interruptions, it will be concluded that RadConnect is a viable alternative to calling that may help reduce radiologist interruptions. The opinions of study participants are captured as Likert scale response and averaged to obtain a consolidated opinion. The consolidated responses are visualized as histograms.	1 hour, after completion of the after phase (phase 2 of this study)